iCAD, Inc. provides artificial intelligence-powered cancer detection. Its ProFound Breast Health Suite enables medical providers and professionals to accurately and reliably identify where cancer may be hiding. Its Cancer Detection segment solutions include advanced artificial intelligence and image analysis workflow solutions that enable healthcare professionals to better serve patients by identifying pathologies and pinpointing the prevalent cancers earlier, a range of upgradeable computer-aided detection systems and workflow solutions for digital breast tomosynthesis, full-field digital mammography, magnetic resonance imaging and computed tomography. ProFound Suite offers 360-degree solutions for cancer detection, density assessment, and personalized risk evaluation, all based on a 2D or 3D mammogramâs collection of images. ProFound Density Assessment standardizes and simplifies breast density reporting, algorithmically examining a womanâs breast anatomy from the mammogram image.
äŒæ¥ã³ãŒãICAD
äŒç€ŸåICAD Inc
äžå Žæ¥Dec 13, 1984
æé«çµå¶è²¬ä»»è
ãCEOãMs. Dana R. Brown
åŸæ¥å¡æ°66
蚌åžçš®é¡Ordinary Share
æ±ºç®ææ«Dec 13
æ¬ç€Ÿæåšå°98 Spit Brook Rd Ste 100
éœåžNASHUA
蚌åžååŒæEuronext Paris
åœUnited States of America
éµäŸ¿çªå·03062-5737
é»è©±çªå·16038825200
ãŠã§ããµã€ãhttps://www.icadmed.com/
äŒæ¥ã³ãŒãICAD
äžå Žæ¥Dec 13, 1984
æé«çµå¶è²¬ä»»è
ãCEOãMs. Dana R. Brown
éå»5幎éã®é
åœéç·æ¯æé¡ã¯
0.00
ç±³ãã«ã§ããã

ããŒã¿ãªã